Page last updated: 2024-08-24

triazoles and Rhabdomyolysis

triazoles has been researched along with Rhabdomyolysis in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's6 (85.71)29.6817
2010's1 (14.29)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kao, DP; Kohrt, HE; Kugler, J1
Boucher, BJ1
DiGregorio, RV; Pasikhova, Y1
Bhome, R; Penn, H1
Samuels, S; Thompson, M1
Monaghan, MS; Skrabal, MZ; Stading, JA1
Foster, G; Gutierrez, MJ; LaBadie, RR; Liu, P; Sharma, A1

Trials

1 trial(s) available for triazoles and Rhabdomyolysis

ArticleYear
Pharmacokinetic interaction between voriconazole and efavirenz at steady state in healthy male subjects.
    Journal of clinical pharmacology, 2008, Volume: 48, Issue:1

    Topics: Adolescent; Adult; Age Factors; Alkynes; Antifungal Agents; Area Under Curve; Benzoxazines; Body Weight; Capsules; Creatine Kinase; Cyclopropanes; Drug Interactions; Heart Block; Humans; Male; Metabolic Clearance Rate; Middle Aged; Pyrimidines; Reverse Transcriptase Inhibitors; Rhabdomyolysis; Tablets; Triazoles; Voriconazole

2008

Other Studies

6 other study(ies) available for triazoles and Rhabdomyolysis

ArticleYear
Renal failure and rhabdomyolysis associated with sitagliptin and simvastatin use.
    Diabetic medicine : a journal of the British Diabetic Association, 2008, Volume: 25, Issue:10

    Topics: Acute Kidney Injury; Aged; Dipeptidyl-Peptidase IV Inhibitors; Drug Therapy, Combination; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Pyrazines; Rhabdomyolysis; Simvastatin; Sitagliptin Phosphate; Triazoles

2008
Renal failure and rhabdomyolysis associated with sitagliptin and simvastatin use. But what about the amiodarone?
    Diabetic medicine : a journal of the British Diabetic Association, 2009, Volume: 26, Issue:2

    Topics: Amiodarone; Contraindications; Dipeptidyl-Peptidase IV Inhibitors; Drug Therapy, Combination; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypolipidemic Agents; Liver-Specific Organic Anion Transporter 1; Male; Organic Anion Transporters; Pyrazines; Renal Insufficiency; Rhabdomyolysis; Simvastatin; Sitagliptin Phosphate; Triazoles; United Kingdom; United States

2009
Rhabdomyolysis caused by a potential sitagliptin-lovastatin interaction.
    Pharmacotherapy, 2009, Volume: 29, Issue:3

    Topics: Aged; Anticholesteremic Agents; Drug Interactions; Drug Therapy, Combination; Female; Humans; Hypoglycemic Agents; Lovastatin; Pyrazines; Rhabdomyolysis; Sitagliptin Phosphate; Triazoles

2009
Rhabdomyolysis precipitated by a sitagliptin-atorvastatin drug interaction.
    Diabetic medicine : a journal of the British Diabetic Association, 2012, Volume: 29, Issue:5

    Topics: Aged; Atorvastatin; Drug Interactions; Drug Therapy, Combination; Heptanoic Acids; Humans; Male; Pyrazines; Pyrroles; Rhabdomyolysis; Sitagliptin Phosphate; Treatment Outcome; Triazoles

2012
Rhabdomyolysis with simvastatin and nefazodone.
    The American journal of psychiatry, 2002, Volume: 159, Issue:9

    Topics: Aged; Antidepressive Agents, Second-Generation; Depressive Disorder; Drug Interactions; Humans; Hyperlipidemias; Hypolipidemic Agents; Male; Piperazines; Rhabdomyolysis; Simvastatin; Triazoles

2002
Rhabdomyolysis associated with simvastatin-nefazodone therapy.
    Southern medical journal, 2003, Volume: 96, Issue:10

    Topics: Antidepressive Agents, Second-Generation; Depressive Disorder; Drug Interactions; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Male; Middle Aged; Piperazines; Rhabdomyolysis; Simvastatin; Triazoles

2003